Amelioration of rat collagen-induced arthritis through CD4+ T cells apoptosis and synovial interleukin-17 reduction by indoleamine 2,3-dioxygenase gene therapy

Human Gene Therapy

Volumn 22, Issue 2, 2011, Pages 145-154

  Chen, Shih Yao ^a   Wu, Chao Liang ^a   Lai, Ming Derg ^a   Lin, Chi Chen ^a   Yo, Yi Te ^a   Jou, I Ming ^a   Lee, Che Hsin ^b   Weng, Chia Tse ^a   Shiau, Ai Li ^a   Wang, Chrong Reen ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD68 ANTIGEN; COLLAGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 17; KYNURENINE; RETINOIC ACID RECEPTOR GAMMA; TRYPTOPHAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ANKLE RADIOGRAPHY; APOPTOSIS; ARTHRITIS; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE OVEREXPRESSION; GENE TRANSFER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPH NODE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; NONHUMAN; PROTEIN EXPRESSION; RAT; SCORING SYSTEM; SYNOVIUM; THERAPY EFFECT; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; ANKLE JOINT; APOPTOSIS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; GENE THERAPY; GENETIC VECTORS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERLEUKIN-17; KYNURENINE; MACROPHAGES; RATS; RATS, SPRAGUE-DAWLEY; SYNOVIAL MEMBRANE; TRYPTOPHAN;

RATTUS;

EID: 79951825632     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.217     Document Type: Article

References (45)

1. Adriaansen, J., Kuhlman, R.R., van Holten, J., Kaynor, C., Ver-voordeldonk, M.J., and Tak, P.P. (2006). Intraarticular inter-feron-beta gene therapy ameliorates adjuvant arthritis in rats. Hum. Gene Ther. 17, 985-996. (Pubitemid 46076740)
2. Annunziato, F., Cosmi, L., Liotta F., Maggi, E., and Romagnani, S. (2009). Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat. Rev. Rheumatol. 5, 325-331.
3. Auckland, G. (1969). Psoriasis and arthritis: treatment with low tryptophan diet. Br. J. Dermatol. 81, 388-389.
4. Bertazzo, A., Punzi, L., Bertazzolo, N., Pianon, M., Pozzuoli, A., Costa, C.V., and Allegri G. (1999). Tryptophan catabolism in synovial fluid of various arthropathies and its relationship with inflammatory cytokines. Adv. Exp. Med. Biol. 467, 565-570. (Pubitemid 32202203)
5. Bianco, N.R., Kim, S.H., Ruffner, M.A., and Robbins, P.D. (2009). Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models. Arthritis Rheum. 60, 380-389.
6. Chabaud, M., Durand, J.M., Buchs, N., Fossiez, F., Page, G., Frappart, L., and Miossec, P. (1999). Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 42, 963-970. (Pubitemid 29215007)
7. Chen, S.Y., Shiau, A.L., Shieh, G.S., Su, C.H., Lee, C.H., Lee, H.L., Wang, C.R., and Wu, C.L. (2009). Amelioration of experimental arthritis by a telomerase-dependent conditionally replicating adenovirus that targets synovial fibroblasts. Arthritis Rheum. 60, 3290-3302.
8. Choy, E.H., and Panayi, GS. (2001). Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344, 907-916. (Pubitemid 32224400)
9. Criado, G., Simelyte, E., Inglis, J.J., Essex, D., and Williams, R.O. (2009). Indoleamine 2,3-dioxygenase-mediated tryptophan ca-tabolism regulates accumulation of TH1/TH17 cells in the joint in collagen-induced arthritis. Arthritis Rheum. 60, 1342-1351.
10. Cron, R.Q. (2005). A signal achievement in the treatment of arthritis. Arthritis Rheum. 52, 2229-2232.
11. Fox, D.A. (1997). The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum. 40, 598-609.
12. Furuzawa-Carballeda, J., Vargas-Rojas, M.I., and Cabral, A.R. (2007). Autoimmune inflammation from the Th17 perspective. Autoimmunity 6, 169-175. (Pubitemid 46187336)
13. Genovese, M., Van den Bosch, F., Roberson, S., Bojin, S., Biagini, I., Ryan, P., and Sloan-Lancaster, J. (2010). LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis; a phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum. 62, 929-939.
14. Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M.L., Bianchi, R., Fioretti, M.C., and Puccetti, P. (2002). CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3, 1097-1101. (Pubitemid 35363664)
15. Higuchi, K., and Hayaishi, O. (1967). Enzymic formation of D-kynurenine from D-tryptophan. Arch. Biochem. Biophys. 120, 397-403.
16. Houpt, J.B., Ogryzlo, M.A., and Hunt, M. (1973). Tryptophan metabolism in man (with special reference to rheumatoid arthritis and scleroderma). Semin. Arthritis Rheum. 2, 333-353.
17. Hsieh, J., Shen, P.C., Shiau, A.L., Wu, C.L., Lee, C.H., Jou, I.M., Wang, C.R., Chao, J., Chao, L., and Teo, M.L. (2009). Adenovirus-mediated kallistatin gene transfer ameliorates disease progression in a rat model of osteoarthritis induced by anterior cruciate ligament transection. Hum. Gene Ther. 20, 147-158.
18. Ijima K., Murakami M., Okamoto H., Inobe M., Chikuma S., Saito I., Kanegae Y., Kawaguchi Y., Kitabatake A., and Uede T. (2001). Successful gene therapy via intraarticular injection of adenovirus vector containing CTLA4IgG in a murine model of type II collagen-induced arthritis. Hum. Gene Ther. 12, 1063-1077. (Pubitemid 32692422)
19. Ivanov, S., and Linden, A. (2009). Interleukin-17 as a drug target in human disease. Trends Pharmacol. Sci. 30, 95-103.
20. Izcue, A., Coombes, J.L., and Powrie, F. (2009). Regulatory lymphocytes and intestinal inflammation. Annu. Rev. Immunol. 27, 313-338.
21. Klareskog, L., Catrina, A.I., and Paget, S. (2009). Rheumatoid arthritis. Lancet 373, 659-672.
22. Lemmel, E.M., Franke, M., Gaus, W., Hartl, P.W., Hofschneider, P.H., Miehlke, K., Machalke, K., and Obert, H.J. (1987). Results of a phase-II clinical trial on treatment of rheumatoid arthritis with recombinant interferon-gamma. Rheumatol. Int. 7, 127-132. (Pubitemid 17156975)
23. \+T cells in pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16, 34-38.
24. Liu, Z., Dai, H., Wan, N., Wang, T., Bertera, S., Trucco, M., and Dai, Z. (2007). Suppression of memory CD8 T cell generation and function by tryptophan catabolism. J. Immunol. 178, 4260-4266. (Pubitemid 46492376)
25. Lu, T.J., Lai, W.Y., Huang, C.Y., Hsieh, W.J., Yu, J.S., Hsieh, Y.J., Chang, W.T., Leu, T.H., Chang, W.C., Chuang, W.J., Tang, M.J., Chen, T.Y., Lu, T.L., and Lai, M.D. (2006). Inhibition of cell migration by autophosphorylated mammalian sterile 20-like kinase 3 (MST3) involves paxillin and protein-tyrosine phosphatase-PEST. J. Biol. Chem. 281, 38405-38417.
26. Matin, A., Streete, I.M., Jamie, I.M., Truscott, R.J., and Jamie, J.F. (2006). A fluorescence-based assay for indoleamine 2,3-diox-ygenase. Anal. Biochem. 349, 96-102.
27. Mauri, C., Williams, R.O., Walmsley, M., and Feldmann, M. (1996). Relation between Th1 and Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur. J. Immunol. 26, 1511-1518. (Pubitemid 26229996)
28. Miossec, P. (2007). Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified. Arthritis Rheum. 56, 2111-2115. (Pubitemid 47173557)
29. Mulley, W.R., and Nikolic-Paterson, D.J. (2008). Indoleamine 2,3-dioxygenase in transplantation. Nephrology (Carlton) 13, 204-211. (Pubitemid 351341466)
30. Panayi, G.S. (1997). T cell-dependent pathways in rheumatoid arthritis. Curr. Opin. Rheumatol. 9, 236-240.
31. Park, M.J., Min, S.Y., Park, K.S., Cho, Y.G., Cho, M.L., Jung, Y.O., Park, H.S., Chang, S.H., Cho, S.G., Min, J.K., Park, S.H., and Kim, H.Y. (2008). Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4\+ CD25\+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model. Arthritis Res. Ther. 10, R11.
32. Romani, L., Zelante, T., De Luca, A., Fallarino, F., and Puccetti, P. (2008). IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J. Immunol. 180, 5157-5162.
33. Schroecksnadel, K., Kaser, S., Ledochowski, M., Neurauter, G., Mur, E., Herold, M., and Fuchs, D. (2003). Increased degradation of tryptophan in blood of patients with rheumatoid arthritis. J. Rheumatol. 30, 1935-1939. (Pubitemid 37075539)
34. Shahrara, S., Huang, Q.Q., Mandelin, A.M. 2nd, and Pope, R.M. (2008). TH-17 cells in rheumatoid arthritis. Arthritis Res. Ther. 10, R93.
35. Shiau, A.L., Chen, S.Y., Chang, M.Y., Su, C.H., Chung, S.Y., Yo, Y.T., Wang, C.R., and Wu, C.L. (2007). Prothymosin alpha lacking the nuclear localization signal as an effective gene therapeutic strategy in collagen-induced arthritis. J. Immunol. 180, 5991-5999.
36. Spiera, H., and Lefkovits, A.M. (1967). Remission of psoriasis with low dietary tryptophan. Lancet 2, 137-139.
37. Szanto, S., Koreny, T., Mikecz, K., Glant, T.T., Szekanecz, Z., and Varga, J. (2007). Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice. Arthritis Res. Ther. 9, R50.
38. Thomaidis, T., Schorn, C., Flaig, W., Lingg, G., Schonhals, E., Klingel, R., Galle, P.R., and Schwarting, A. (2009). Im-munoadsorption with tryptophan columns: a therapeutic option for the treatment of rheumatoid arthritis with septic complications. J. Clin. Apheresis 24, 37-41.
39. Wang, C.R., and Liu, M.F. (2003). Regulation of CCR5 expression and MIP-1a production in CD4\+ T cells from patients with rheumatoid arthritis. Clin. Exp. Immunol. 132, 371-378. (Pubitemid 36560638)
40. Wang, C.R., Chen, S.Y., Wu, C.L., Liu, M.F., Jin, Y.T., Chao, L., and Chao, J. (2005). Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation. Arthritis Rheum. 52, 1319-1324. (Pubitemid 40530143)
41. Wang, C.R., Shiau, A.L., Chen, S.Y., Lin, L.L., Tai, M.H., Shieh, G.S., Lin, P.R., Yo, Y.T., Lee, C.H., Kuo, S.M., Liu, M.F., Jou, I.M., Yang, C.Y., Shen, P.C., Lee, H.L., and Wu, C.L. (2008). Amelioration of collagen-induced arthritis in rats by adeno-virus-mediated PTEN gene transfer. Arthritis Rheum. 58, 1650-1656.
42. Weber, W.P., Feder-Mengus, C., Chiarugi, A., Rosenthal, R., Reschner, A., Schumacher, R., Zajac, P., Misteli, H., Frey, D.M., Oertli, D., Heberer, M., and Spagnoli, G.C. (2006). Differential effects of the tryptophan metabolite 3-hydro-xyanthranilic acid on the proliferation of human CD8\+ T cells induced by TCR triggering or homeostatic cytokines. Eur. J. Immunol. 36, 296-304. (Pubitemid 43257452)
43. Wehling, P., Reinecke, J., Baltzer, A.A., Granrath, M., Schulitz, K.P., Schultz, C., Krauspe, R., Whiteside, T., Elder, E., Ghi-vizzani, S.C., Robbins, P.D., and Evans, C.H. (2009). Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis. Hum. Gene Ther. 20, 97-101.
44. Wu, M.T., Wu, R.H., Hung, C.F., Tsai, W.H., and Chang, W.T. (2005). Simple and efficient DNA vector-based RNAi systems in mammalian cells. Biochem. Biophys. Res. Commun. 330, 53-59.
45. Yen, M.C., Lin, C.C., Chen, Y.L., Huang, S.S., Yang, H.J., Chang, C.P., Lei, H.Y., and Lai, M.D. (2009). A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA. Clin. Cancer Res. 15, 641-649.